The White House is finalizing a rule that could impact patients’ prescription drug costs. The rule involves “copay accumulators,” which prevent copay assistance from counting towards deductibles or out-of-pocket maximums. A judge overturned a 2021 rule allowing the use of copay accumulators in September, with HHS and CMS appealing the decision. Patients with conditions like cancer and HIV rely on copay assistance to afford expensive medications. Employers using copay accumulators took nearly $5 billion in assistance from patients last year. Patient advocacy groups are urging the White House to drop the appeal and protect cost-sharing protections for Americans.
Source link
An Upcoming White House Decision May Jeopardize Americans’ Access to Life-Saving Drugs
